Added to YB: 2025-11-11
Pitch date: 2025-11-07
SNN [neutral]
Smith & Nephew plc
-3.68%
current return
Author Info
No bio for this author
Company Info
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
Market Cap
GBP 13.8B
Pitch Price
GBP 12.62
Price Target
N/A
Dividend
2.34%
EV/EBITDA
11.20
P/E
29.17
EV/Sales
2.79
Sector
Health Care Equipment and Supplies
Category
value
Stocks Update 7/11/2025 - Smith & Nephew (SNN)
SNN (update): Q3 revenue $1.5bn (+5% CER), all divisions up 4-6%. Completed $500M buyback, raised FCF guidance from >$600M to >$750M on strong working capital discipline. Reaffirmed 5% revenue growth & 19-20% trading margin outlook. Trades 13.8x 2026 consensus earnings, 2.8% yield - undervalued vs transformation progress.
Read full article (1 min)